Patient Pathfinder: Clinical Trials
Clinical Trials for Bladder Cancer
Every life-saving or life-extending treatment that’s available today for cancer started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand cancer, and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 278 active Bladder Cancer trials
A Study of MGC026 in Participants With Advanced Solid Tumors
Study Type: Interventional Phase 1
Artificial Intelligence Prediction Tool in Non-muscle Invasive Bladder Cancer (NMIBC)
Study Type: Observational
Study of CG0070 After Transurethral Resection in Patients With IR NMIBC
Study Type: Interventional Phase 1
Integrated Actionable Aging Assessment for Cancer Patients Pilot
Study Type: Interventional
Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2)
Study Type: Interventional Phase 2
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder for Bladder Cancer Treatment, MODERN Study
Study Type: Interventional Phase 3
Bladder and Bone Effects of Pelvic Radiation Therapy in Childhood Cancer Survivors
Study Type: Observational
Reduction of Gastrointestinal Toxicity in Prostate Cancer by Proton Spot Placement
Study Type: Interventional
There are 278 active Bladder Cancer trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now